+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Radioimmunoassay for an analog of thyrotrophin-releasing hormone, gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide (DN-1417)



Radioimmunoassay for an analog of thyrotrophin-releasing hormone, gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide (DN-1417)



Journal of Immunological Methods 51(1): 69-80



A heterologous radioimmunoassay method was established to determine plasma levels of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide (DN-1417). As this compound is unstable in the incubation buffer, we introduced a conversion step. DN-1417 in the plasma was extracted with a solution of isopropanol-isobutylamine (4 : 1) and incubation was performed at room temperature for 2 h for the conversion of DN-1417 into N-[2-hydroxy-4-(isobutylcarbamoyl)butyryl]-L-histidyl-L-prolinamide (DN-isobutylamide). 125I-labeled 2-hydroxy-4-carboxybutyryl-L-histidyl-L-prolinamide and antisera, which was raised in the rabbit using an esterified derivative of DN-1417 conjugated with BSA as an antigen, were used for a sensitive radioimmunoassay of DN-isobutylamide. In this system, 0.2 ng DN-isobutylamide/ml plasma, equivalent to 0.16 ng DN-1417/ml, was detected and there was no apparent interference from its metabolites. The within-assay coefficients of variation were 7.6% at 7.73 ng/tube and 13.7% at 1.32 ng/tube. The between-assay coefficients of variation were 16.1% at 6.43 ng/tube and 12.2% at 1.20 ng/tube. The mean recovery rate of the assay system was 76.0 +/- 3.2% (S.E.M.).

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 044127870

Download citation: RISBibTeXText

PMID: 6809831


Related references

Absorption of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide citrate (DN-1417), an analog of thyrotropin-releasing hormone, in rats and dogs. Journal of Pharmacobio-Dynamics 7(8): 527-535, 1984

Kinetic study on disappearance of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide (DN-1417) from plasma using a radioimmunoassay for DN-1417 isobutylamide. Journal of Pharmacobio-Dynamics 6(3): 202-208, 1983

Intestinal absorption mechanisms of gamma-butyrolactone-gamma-carbonyl-L-histidyl-L-prolinamide citrate (DN-1417) and thyrotropin-releasing hormone (TRH). Journal of Pharmacobio-Dynamics 8(4): 278-285, 1985

Effect of trh and its analog dn 1417 gamma butyrolactone gamma carbonyl l histidyl l prolinamide citrate on anoxia induced amnesia in mice. Japanese Journal of Psychopharmacology 5(1): 1-10, 1985

Gamma-butyrolactone-gamma-carbonyl-histidyl-prolinamide citrate (DN-1417): a novel TRH analog with potent effects on the central nervous system. Life Sciences 28(8): 861-869, 1981

Gamma butyro lactone gamma carbonyl histidyl prolinamide citrate dn 1417 a novel thyrotropin releasing hormone analog with potent effects on the central nervous system. Life Sciences 28(8): 861-870, 1981

The effect of a novel trh analog dn 1417 gamma butyrolactone gamma carbonyl l histidyl l prolinamide citrate on postictal seizure inhibition in amygdaloid kindled cats. Brain & Nerve 36(10): 951-955, 1984

Preclinical drug screening a model of a clinical autorefractory state with trh but not with the more excitatory analog dn 1417 gamma butyrolactone gamma carbonyl histidyl prolinamide citrate. Annals of Neurology 18(1): 150, 1985

Trh and its analog dn 1417 gamma butyrolactone gamma carbonyl l histidyl l prolinamide interaction with pento barbital in choline uptake and acetyl choline synthesis of rat brain slices. Life Sciences 32(14): 1637-1646, 1983

Anti epileptic effects on trh tartrate and dn 1417 gamma butyrolactone gamma carbonyl l histidyl l prolinamide citrate. Kurume Medical Journalppl: S57-S64, 1983

A trh analog dn 1417 gamma butyrolactane gamma carbonyl histidyl prolinamide citrate increases endogenous dopamine release from slices of rat striatum and nucleus accumbens. Kurume Medical Journalppl: S29-236, 1983

Effects of trh and its analog dn 1417 gamma butyrolactone gamma carbonylhistidyl prolinamide citrate on neuronal activity in rat brain. Neuroscience Letters (Suppl. 13): S115, 1983

A trh analog dn 1417 gamma butyro lactone gamma carbonyl l histidyl l prolinamide citrate effects on local cerebral glucose utilization in conscious and pento barbitalized rats determined by the auto radiographic 2 deoxy carbon 14 labeled glucose method. Japanese Journal of Pharmacology 33(3): 635-646, 1983

Effect of a trh analog dn 1417 gamma butyrolactone gamma carbonylhistidyl prolinamide citrate on tyrosine hydroxylase activity in discrete areas of rat brain. Kurume Medical Journal 30(Suppl.): S37-S44, 1983

Effects of trh and an analog dn 1417 gamma butyrolactone gamma carbonylhistidyl prolinamide citrate on the activities of single neurons in the nucleus accumbens cerebral cortex and caudate putamen of rats. Kurume Medical Journal 30(Suppl.): S19-S28, 1983